The guide, which is available on the ABPI website, includes a joint working framework and criteria to support a productive partnership approach. It also highlights examples of case studies of joint working that have delivered real improvements for patients and adopted innovative approaches in areas such as asthma care and reducing chronic obstructive pulmonary disease (COPD).
The ABPI and NHS England have a shared ambition to see many more joint working projects. Commenting on the publication of the Guide, Carol Blount ABPI’s NHS Partnership Director said:
“The ABPI is committed to supporting joint working and we have a regional team dedicated to helping industry and the NHS to work together. I really hope that this guide will inspire people to look for opportunities to set-up new projects that will bring innovative ways of working, benefit patients and make services more efficient and effective.”
The guide was compiled using a wide range of experience from ABPI members.
Notes to editor
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.